Olfactory involvement in aging and Alzheimer's disease: An autopsy study

Journal of Alzheimer's Disease

Volumn 7, Issue 2, 2005, Pages 149-157

  Attems, Johannes ^a   Lintner, Felix ^a   Jellinger, Kurt A ^b  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^b INSTITUTE OF CLINICAL NEUROBIOLOGY   (Austria)

Author keywords

Alzheimer disease; Dementia; Olfactory system; Tau pathology

Indexed keywords

TAU PROTEIN;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DISEASE SEVERITY; FEMALE; HUMAN; LIMBIC SYSTEM; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROPIL; OLFACTORY BULB; OLFACTORY SYSTEM; PRIORITY JOURNAL; PROTEIN ANALYSIS; SMELLING; STATISTICAL SIGNIFICANCE;

EID: 17844363943     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2005-7208     Document Type: Article

References (71)

1. J.E. Ahlskog, S.C. Waring, R.C. Petersen, C. Esteban-Santillan, U.K. Craig, P.C. O'Brien, M.F. Plevak and L.T. Kurland, Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia, Neurology 51 (1998), 1672-1677.
2. K.A. Ansari and A. Johnson, Olfactory function in patients with Parkinson's disease, J Chronic Dis 28 (1975), 493-497.
3. S.E. Arnold, G.S. Smutzer, J.Q. Trojanowski and P.J. Moberg, Cellular and molecular neuropathology of the olfactory epithelium and central olfactory pathways in Alzheimer's disease and schizophrenia, Ann N Y Acad Sci 855 (1998), 762-775.
4. P. Averback, Two new lesions in Alzheimer's disease, Lancet 2 (1983), 1203.
5. A.W. Bacon, M.W. Bondi, D.P. Salmon and C. Murphy, Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction, Ann N Y Acad Sci 855 (1998), 723-731.
6. H. Braak and E. Braak, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol (Berl) 82 (1991), 239-259.
7. H. Braak, K. Del Tredici, U. Rub, R.A. de Vos, E.N. Jansen Steur and E. Braak, Staging of brain pathology related to sporadic Parkinson's disease, Neurobiol Aging 24 (2003), 197-211.
8. S. Christen-Zaech, R. Kraftsik, O. Pillevuit, M. Kiraly, R. Martins, K. Khalili and J. Miklossy, Early olfactory involvement in Alzheimer's disease, Can J Neurol Sci 30 (2003), 20-25.
9. D.C. Davies, J.W. Brooks and D.A. Lewis, Axonal loss from the olfactory tracts in Alzheimer's disease, Neurobiol Aging 14 (1993), 353-357.
10. R.L. Doty, D.R Perl, J.C. Steele, K.M. Chen, J.D. Pierce, Jr., P. Reyes and L.T. Kurland, Odor identification deficit of the parkinsonism-dementia complex of Guam: equivalence to that of Alzheimer's and idiopathic Parkinson's disease, Neurology 41(Suppl 2) (1991), 77-80.
11. R.L. Doty, M.B. Stern, C. Pfeiffer, S.M. Gollomp and H.I. Hurtig, Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease, J Neurol Neurosurg Psychiatry 55 (1992), 138-142.
12. J.E. Duda, U. Shah, S.E. Arnold, V.M. Lee and J.Q. Trojanowski, The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases, Exp Neurol 160 (1999), 515-522.
13. M.M. Esiri and O.K. Wilcock, The olfactory bulbs in Alzheimer's disease, J Neurol Neurosurg Psychiatry 47 (1984), 56-60.
14. R.P. Friedland, E. Koss, A. Kumar, S. Gaine, D. Metzler, J.V. Haxby and A. Moore, Motor vehicle crashes in dementia of the Alzheimer type, Ann Neurol 24 (1988), 782-786.
15. A.B. Graves, J.D. Bowen, L. Rajaram, W.C. McCormick, S.M. McCurry, G.D. Schellenberg and E.B. Larson, Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon 4 status, Neurology 53 (1999), 1480-1487.
16. C. Hawkes, Olfaction in neurodegenerative disorder, it Mov Disord 18 (2003), 364-372.
17. C.H. Hawkes and B.C. Shephard, Selective anosmia in Parkinson's disease?, Lancet 341 (1993), 435-436.
18. J.M. Henderson, Y. Lu, S. Wang, H. Cartwright and G.M. Halliday, Olfactory deficits and sleep disturbances in Parkinson's disease: a case-control survey, J Neurol Neurosurg Psychiatry 74 (2003), 956-958.
19. T. Hirai, S. Kojima, A. Shimada, T. Umemura, M. Sakai and C. Itakura, Age-related changes in the olfactory system of dogs, Neuropathol Appl Neurobiol 22 (1996), 531-539.
20. C. Hock, S. Golombowski, F. Muller-Spahn, O. Peschel, A. Riederer, A. Probst, E. Mandelkow and J. Unger, Histological markers in nasal mucosa of patients with Alzheimer's disease, Eur Neurol 40 (1998), 31-36.
21. P.V. Hoogland, R. van den Berg and E. Huisman, Misrouted olfactory fibres and ectopic olfactory glomeruli in normal humans and in Parkinson and Alzheimer patients, Neuropathol Appl Neurobiol 29 (2003), 303-311.
22. AJ. Hughes, S.E. Daniel, Y. Ben-Shlomo and AJ. Lees, The accuracy of diagnosis ofparkinsonian syndromes in a specialist movement disorder service, Brain 125 (2002), 861-870.
23. L.F. Hughes, R.G. Struble and C.L. Shaffer, Olfaction in elderly and patients with Alzheimer's disease: Differing feedback conditions, J Aizheimers Dis 3 (2001), 367-375.
24. B.T. Hyman, B.V. Arrigada and G.W. Van Hoesen, Pathologic changes in the olfactory system in aging and Alzheimer's disease, Ann NY Acad Sci 640 (1997), 14-19.
25. K.A. Jellinger, Lewy body-related alpha-synucleinopathy in the aged human brain, J Neural Transm 111 (2004), 1219-1235.
26. K.A. Jellinger and J. Attems, Scientific correspondence, Neuropathol Appl Neurobiol (2004), in press.
27. S. Kaakkola, J. Palo, H. Malmberg, R. Sulkava and I. Virtanen, Neurofilament profile in olfactory mucosa of patients with a clinical diagnosis of Alzheimer's disease, Virchows Arch 424 (1994), 315-319.
28. R. Katzenschlager and AJ. Lees, Olfaction and Parkinson's syndromes: its role in differential diagnosis, Curr Opin Neurol 17 (2004), 417-423.
29. R. Katzenschlager, J. Zijlmans, A. Evans, H. Watt and AJ. Lees, Olfactory function distinguishes vascular parkinsonism from Parkinson's disease, J Neurol Neurosurg Psychiatry 75 (2004), 1749-1752.
30. J.P. Kesslak, C.W. Cotman, H.C. Chui, S. Van den Noort, H. Fang, R. Pfeffer and G. Lynch, Olfactory tests as possible probes for detecting and monitoring Alzheimer's disease, Neurobiol Aging 9 (1988), 399-403.
31. E. Koss, J.M. Weiffenbach, J.V. Haxby and R.P. Friedland, Olfactory detection and identification performance are dissociated in early Alzheimer's disease, Neurology 38 (1988), 1228-1232.
32. T. Kovacs, NJ. Cairns and PL. Lantos, beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease, Neuropathol Appl Neurobiol 25(1999), 481-491.
33. T. Kovacs, NJ. Cairns and PL. Lantos, Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages, Neuroreport 12 (2001), 285-288.
34. M. Larsson, H. Semb, B. Winblad, K. Amberla, L.O. Wahlund and L. Backman, Odor identification in normal aging and early Alzheimer's disease: effects of retrieval support, Neuropsychology 13 (1999), 47-53.
35. J.H. Lee, M. Goedert, W.D. Hill, V.M. Lee and J.Q. Trojanowski, Tau proteins are abnormally expressed in olfactory epithelium of Alzheimer patients and developmentally regulated in human fetal spinal cord, Exp Neurol 121 (1993), 93-105.
36. J. Lewis, D.W. Dickson, W.L. Lin, L. Chisholm, A. Corral, G. Jones, S.H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton and E. McGowan, Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP, Science 293 (2001), 1487-1491.
37. L.D. Loopuijt and J.B. Sebens, Loss of dopamine receptors in the olfactory bulb of patients with Alzheimer's disease, Brain Res 529 (1990), 239-244.
38. J.B. Macknin, M. Higuchi, VM. Lee, J.Q. Trojanowski and R.L. Doty, Olfactory dysfunction occurs in transgenic mice overexpressing human tau protein, Brain Res 1000 (2004), 174-178.
39. D.M. Mann, C.M. Tucker and P.O. Yates, Alzheimer's disease: an olfactory connection?, Mech Ageing Dev 42 (1988), 1-15.
40. I.G. McKeith, D. Galasko, K. Kosaka, E.K. Perry, D.W. Dickson, L.A. Hansen, D.P. Salmon, J. Lowe, S.S. Mirra, EJ. Byrne, G. Lennox, N.P. Quinn, J.A. Edwardson, P.G. Ince, C. Bergeron, A. Burns, B.L. Miller, S. Lovestone, D. Collerton, E.N. Jansen, C. Ballard, R.A. de Vos, G.K. Wilcock, K.A. Jellinger and R.H. Perry, Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop, Neurology 47 (1996), 1113-1124.
41. R.H. McShane, Z. Nagy, M.M. Esiri, E. King, C. Joachim, N. Sullivan and A.D. Smith, Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology, J Neurol Neurosurg Psychiatry 70 (2001), 739-743.
42. R.I. Mesholam, P.J. Moberg, R.N. Mahr and R.L. Doty, Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases, Arch Neurol 55 (1998), 84-90.
43. S.S. Mirra, A. Heyman, D. McKeel, S.M. Sumi, B.J. Crain, L.M. Brownlee, F.S. Vogel, J.P. Hughes, G. van Belle and L. Berg, The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease, Neurology 41 (1991), 479-486.
44. C.D. Morgan, S. Nordin and C. Murphy, Odor identification as an early marker for Alzheimer's disease: impact of lexical functioning and detection sensitivity, J Clin Exp Neuropsychol 17(1995), 793-803.
45. A. Muller, M. Mungersdorf, H. Reichmann, G. Strehle and T. Hummel, Olfactory function in Parkinsonian syndromes, J Clin Neurosci 9 (2002), 521-524.
46. A. Mueller, N.D. Abolmaali, A.R. Hakimi, T. Gloeckler, B. Herting, H. Reichmann and T. Hummel, Olfactory bulb volumes in patients with idiopathic Parkinson's disease a pilot study, J Neural Transm (Feb. 15, 2005), Online, DOI: 10.1007/s00702-00005-00280-X.
47. C. Murphy, M.M. Gilmore, C.S. Seery, O.P. Salmon and B.R. Lasker, Olfactory thresholds are associated with degree of dementia in Alzheimer's disease, Neurobiol Aging 11 (1990), 465-469.
48. C. Murphy and S. Jinich, Olfactory dysfunction in Down's Syndrome, Neurobiol Aging 17 (1996), 631-637.
49. S. Nordin and C. Murphy, Impaired sensory and cognitive olfactory function in questionable Alzheimer's disease, Neuropsychology 10 (1996), 113-199.
50. J.M. Nores, B. Biacabe and P. Bonfils, [Olfactory disorders in Alzheimer's disease and in Parkinson's disease. Review of the literature], Ann Med Interne (Paris) 151 (2000), 97-106.
51. T.G. Ohm and H. Braak, Olfactory bulb changes in Alzheimer's disease, Acta Neuropathol (Berl) 73 (1987), 365-369.
52. R.K. Pearce, C.H. Hawkes and S.E. Daniel, The anterior olfactory nucleus in Parkinson's disease, Mov Disord 10 (1995), 283-287.
53. M.M. Ponsen, D. Stoffers, J. Booij, B.L. Van Eck-Smit, E. Walters and H.W. Berendse, Idiopathic hyposmia as a preclinical sign of Parkinson's disease, Ann Neurol 56 (2004), 173-181.
54. P.F. Reyes, D.A. Deems and M.G. Suarez, Olfactory-related changes in Alzheimer's disease: a quantitative neuropathologic study, Brain Res Bull 32 (1993), 1-5.
55. D.L. Rezek, Olfactory deficits as a neurologic sign in dementia of the Alzheimer type, Arch Neurol 44 (1987), 1030-1032.
56. D.R. Royall, L.K. Chiodo, M.S. Polk and C.J. Jaramillo, Severe dysosmia is specifically associated with Alzheimer-like memory deficits in nondemented elderly retirees, Neuroepidemiology 21 (2002), 68-73.
57. S.S. Schiffman, E.G. Graham, E.A. Sattely-Miller, J. Zervakis and K. Welsh-Bohmer, Taste, smell and neuropsychological performance of individuals at familial risk for Alzheimer's disease, Neurobiol Aging 23 (2002), 397-404.
58. M. Serby, P. Larson and D. Kalkstein, The nature and course of olfactory deficits in Alzheimer's disease, Am J Psychiatry 148(1991), 357-360.
59. M. Sliger, T. Lander and C. Murphy, Effects of the ApoE epsilon4 allele on olfactory function in Down syndrome, J Alzheimers Dis 6 (2004), 397-402; discussion 443-399.
60. R.G. Struble and H.B. Clark, Olfactory bulb lesions in Alzheimer's disease, Neurobiol Aging 13 (1992), 469-473.
61. M. Tabaton, S. Cammarata, G.L. Mancardi, G. Cordone, G. Perry and C. Loeb, Abnormal tau-reactive filaments in olfactory mucosa in biopsy specimens of patients with probable Alzheimer's disease, Neurology 41 (1991), 391-394.
62. B.R. Talamo, R. Rudel, K.S. Kosik, V.M. Lee, S.Neff, L. Adelman and J.S. Kauer, Pathological changes in olfactory neurons in patients with Alzheimer's disease, Nature 337 (1989), 736-739.
63. B.R. Talamo, W.H. Feng, M. Perez-Cruet, L. Adelman, K. Kosik, M.Y. Lee, L.C. Cork and J.S. Kauer, Pathologic changes in olfactory neurons in Alzheimer's disease, Ann N Y Acad Sci 640 (1991), 1-7.
64. H.J. ter Laak, K. Renkawek and F.P. van Workum, The olfactory bulb in Alzheimer disease: a morphologic study of neuron loss, tangles, and senile plaques in relation to olfaction, Alzheimer Dis Assoc Disord 8 (1994), 38-48.
65. M.D. Thompson, K. Knee and C.J. Golden, Olfaction in persons with Alzheimer's disease, Neuropsychol Rev 8 (1998), 11-23.
66. G. Tissingh, H.W. Berendse, P. Bergmans, R. DeWaard, B. Dmkarch, J.C. Stoof and B.C. Wolters, Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis, Mov Disord 16 (2001), 41-46.
67. J.Q. Trojanowski, P.D. Newman, W.D. Hill and V.M. Lee, Human olfactory epithelium in normal aging, Alzheimer's disease, and other neurodegenerative disorders, J Comp Neurol 310(1991), 365-376.
68. Y. Tsuboi, Z. K. Wszolek, N.R. Graff-Radford, N. Cookson and D.W. Dickson, Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4, Neuropathol Appl Neurobiol 29 (2003), 503-510.
69. M. Yamagishi and Y. Ishizuka, [Abnormal tau protein expression in biopsied human olfactory mucosa], Nippon Jibiinkoka Gakkai Kaiho 97 (1994), 466-472.
70. M. Yamagishi, Y. Ishizuka and K. Seki, Pathology of olfactory mucosa in patients with Alzheimer's disease, Ann Otol Rhinol Laryngol 103 (1994), 421-427.
71. M. Yamagishi, Y. Ishizuka and K. Seki, [Definitive diagnosis of Alzheimer's disease using olfactory mucosal biopsy], Nippon Jibiinkoka Gakkai Kaiho 97 (1994), 51-60.